4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001604457-26-000007
Options or other derivatives
- CEO acquired 1,236,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Walker Neal · CEO
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-02 | Grant or award : show line 1 in the form Restricted Stock Units | +274,800 | 274,800 | D |
| 2026-02-02 | Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) | +961,700 | 961,700 | D |
Loading xslF345X05/form4-02062026_110224.xml…